Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-02 @ 8:52 AM
Study NCT ID:
NCT04175912
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-17
First Post:
2019-11-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Cholangiocarcinoma | View |
| None | Metastatic Hepatocellular Carcinoma | View |
| None | Stage III Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | View |
| None | Stage IIIA Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | View |
| None | Stage IIIB Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | View |
| None | Stage IV Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | View |
| None | Stage IVA Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IVB Hepatocellular Carcinoma AJCC v8 | View |
| None | Unresectable Cholangiocarcinoma | View |
| None | Unresectable Hepatocellular Carcinoma | View |
| None | Unresectable Intrahepatic Cholangiocarcinoma | View |
Keywords: